Crescent Biopharma (CBIO) Cash from Operations (2013 - 2026)
Crescent Biopharma (CBIO) reported Cash from Operations of 8900000.0 for Q1 2026, up 17.98% year-over-year from 7543657.24 in Q1 2025, and up 66.68% quarter-over-quarter from 26708000.0 in Q4 2025.
Crescent Biopharma (CBIO) Cash from Operations (2013 - 2026) Analysis & Trends
Crescent Biopharma (CBIO) has 14 years of Cash from Operations data on file, last reported at 8900000.0 in Q1 2026.
- Cash from Operations for Q1 2026 came in at 8900000.0, up 17.98% year-over-year; the trailing twelve-month figure through Mar 2026 was 69549000.0 (down 167.36% YoY), and the FY2025 annual result was 71500000.0, down 129.9% from the prior year.
- Cash from Operations grew to 8900000.0 in Q1 2026 per CBIO's latest filing, from 26708000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 6269000.0 in Q4 2024 and troughed at 26708000.0 in Q4 2025.
- A 5-year average of 11713037.19 and a median of 9704414.5 in 2024 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2023 and 2025: Cash from Operations soared 57.03% in 2023, then tumbled 326.03% in 2025.
- A 5-year view of Cash from Operations shows it stood at 7911569.0 in 2022, then grew by 3.75% to 7614997.0 in 2023, then gained by 17.68% to 6269000.0 in 2024, then slumped by 326.03% to 26708000.0 in 2025, then surged by 66.68% to 8900000.0 in 2026.
- Business Quant data shows CBIO's Cash from Operations at 8900000.0 in Q1 2026, 26708000.0 in Q4 2025, and 17492000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Crescent Biopharma | 486.92 Mn | 297.76 Mn | - | -8.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.90 Mn |
| Mar 31, 2026 | -8.90 Mn |
| Dec 31, 2025 | -26.71 Mn |
| Dec 31, 2025 | -26.71 Mn |
| Sep 30, 2025 | -17.49 Mn |
| Sep 30, 2025 | -17.49 Mn |
| Jun 30, 2025 | -16.45 Mn |
| Jun 30, 2025 | -16.45 Mn |
| Mar 31, 2025 | -10.85 Mn |
| Mar 31, 2025 | -10.85 Mn |
| Dec 31, 2024 | -6.27 Mn |
| Dec 31, 2024 | -6.27 Mn |
| Jun 30, 2024 | -8.89 Mn |
| Jun 30, 2024 | -8.89 Mn |
| Mar 31, 2024 | -10.51 Mn |
| Mar 31, 2024 | -10.51 Mn |
| Dec 31, 2023 | -7.61 Mn |
| Dec 31, 2023 | -7.61 Mn |
| Sep 30, 2023 | -8.68 Mn |
| Sep 30, 2023 | -8.68 Mn |